Nordson (NDSN)
Market Price (2/13/2026): $294.96 | Market Cap: $16.5 BilSector: Industrials | Industry: Industrial Machinery & Supplies & Components
Nordson (NDSN)
Market Price (2/13/2026): $294.96Market Cap: $16.5 BilSector: IndustrialsIndustry: Industrial Machinery & Supplies & Components
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 26% | Trading close to highsDist 52W High is -0.4%, Dist 3Y High is -0.4% | Key risksNDSN key risks include [1] foreign currency volatility impacting its substantial international revenue and [2] the effective execution and integration of its acquisition-based growth strategy. |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 26%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 24% | Weak multi-year price returns2Y Excs Rtn is -21%, 3Y Excs Rtn is -39% | |
| Low stock price volatilityVol 12M is 27% | ||
| Megatrend and thematic driversMegatrends include Automation & Robotics, Advanced Materials, and Circular Economy & Recycling. Themes include Factory Automation, Show more. |
| Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 26% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 26%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 24% |
| Low stock price volatilityVol 12M is 27% |
| Megatrend and thematic driversMegatrends include Automation & Robotics, Advanced Materials, and Circular Economy & Recycling. Themes include Factory Automation, Show more. |
| Trading close to highsDist 52W High is -0.4%, Dist 3Y High is -0.4% |
| Weak multi-year price returns2Y Excs Rtn is -21%, 3Y Excs Rtn is -39% |
| Key risksNDSN key risks include [1] foreign currency volatility impacting its substantial international revenue and [2] the effective execution and integration of its acquisition-based growth strategy. |
Qualitative Assessment
AI Analysis | Feedback
Nordson (NDSN) stock has gained about 25% since 10/31/2025 because of the following key factors:
1. Strong Fourth Quarter and Fiscal Year 2025 Earnings Exceeding Expectations: Nordson reported an adjusted EPS of $3.03 for Q4 2025, surpassing analyst forecasts of $2.93, which propelled a 6.89% surge in the stock price to $252.60 following the announcement. The company also achieved record full-year fiscal 2025 sales of $2.8 billion (up 4% year-over-year) and adjusted EPS of $10.24, alongside robust operational efficiency with a 55% gross margin and 136% free cash flow conversion.
2. Optimistic Fiscal Year 2026 Guidance and Growth Projections: Management provided a positive outlook for fiscal year 2026, projecting sales growth between 1% and 6% and adjusted EPS growth ranging from 6% to 12%, with full-year adjusted earnings expected between $10.80 and $11.50 per diluted share. This favorable guidance for future performance contributed to investor confidence.
Show more
1. Strong Fourth Quarter and Fiscal Year 2025 Earnings Exceeding Expectations: Nordson reported an adjusted EPS of $3.03 for Q4 2025, surpassing analyst forecasts of $2.93, which propelled a 6.89% surge in the stock price to $252.60 following the announcement. The company also achieved record full-year fiscal 2025 sales of $2.8 billion (up 4% year-over-year) and adjusted EPS of $10.24, alongside robust operational efficiency with a 55% gross margin and 136% free cash flow conversion.
2. Optimistic Fiscal Year 2026 Guidance and Growth Projections: Management provided a positive outlook for fiscal year 2026, projecting sales growth between 1% and 6% and adjusted EPS growth ranging from 6% to 12%, with full-year adjusted earnings expected between $10.80 and $11.50 per diluted share. This favorable guidance for future performance contributed to investor confidence.
Show more
Stock Movement Drivers
Fundamental Drivers
The 27.5% change in NDSN stock from 10/31/2025 to 2/12/2026 was primarily driven by a 19.0% change in the company's P/E Multiple.| (LTM values as of) | 10312025 | 2122026 | Change |
|---|---|---|---|
| Stock Price ($) | 231.15 | 294.67 | 27.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,784 | 2,792 | 0.3% |
| Net Income Margin (%) | 16.3% | 17.4% | 6.2% |
| P/E Multiple | 28.7 | 34.1 | 19.0% |
| Shares Outstanding (Mil) | 56 | 56 | 0.7% |
| Cumulative Contribution | 27.5% |
Market Drivers
10/31/2025 to 2/12/2026| Return | Correlation | |
|---|---|---|
| NDSN | 27.5% | |
| Market (SPY) | -0.1% | 52.7% |
| Sector (XLI) | 11.4% | 64.9% |
Fundamental Drivers
The 38.5% change in NDSN stock from 7/31/2025 to 2/12/2026 was primarily driven by a 26.1% change in the company's P/E Multiple.| (LTM values as of) | 7312025 | 2122026 | Change |
|---|---|---|---|
| Stock Price ($) | 212.68 | 294.67 | 38.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,704 | 2,792 | 3.2% |
| Net Income Margin (%) | 16.5% | 17.4% | 5.1% |
| P/E Multiple | 27.0 | 34.1 | 26.1% |
| Shares Outstanding (Mil) | 57 | 56 | 1.3% |
| Cumulative Contribution | 38.5% |
Market Drivers
7/31/2025 to 2/12/2026| Return | Correlation | |
|---|---|---|
| NDSN | 38.5% | |
| Market (SPY) | 8.1% | 51.1% |
| Sector (XLI) | 14.1% | 67.4% |
Fundamental Drivers
The 35.8% change in NDSN stock from 1/31/2025 to 2/12/2026 was primarily driven by a 28.4% change in the company's P/E Multiple.| (LTM values as of) | 1312025 | 2122026 | Change |
|---|---|---|---|
| Stock Price ($) | 217.04 | 294.67 | 35.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,690 | 2,792 | 3.8% |
| Net Income Margin (%) | 17.4% | 17.4% | -0.1% |
| P/E Multiple | 26.6 | 34.1 | 28.4% |
| Shares Outstanding (Mil) | 57 | 56 | 2.0% |
| Cumulative Contribution | 35.8% |
Market Drivers
1/31/2025 to 2/12/2026| Return | Correlation | |
|---|---|---|
| NDSN | 35.8% | |
| Market (SPY) | 14.2% | 74.4% |
| Sector (XLI) | 26.1% | 78.5% |
Fundamental Drivers
The 25.8% change in NDSN stock from 1/31/2023 to 2/12/2026 was primarily driven by a 30.6% change in the company's P/E Multiple.| (LTM values as of) | 1312023 | 2122026 | Change |
|---|---|---|---|
| Stock Price ($) | 234.30 | 294.67 | 25.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 2,590 | 2,792 | 7.8% |
| Net Income Margin (%) | 19.8% | 17.4% | -12.4% |
| P/E Multiple | 26.1 | 34.1 | 30.6% |
| Shares Outstanding (Mil) | 57 | 56 | 2.0% |
| Cumulative Contribution | 25.8% |
Market Drivers
1/31/2023 to 2/12/2026| Return | Correlation | |
|---|---|---|
| NDSN | 25.8% | |
| Market (SPY) | 73.8% | 62.0% |
| Sector (XLI) | 77.0% | 72.3% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| NDSN Return | 28% | -6% | 12% | -20% | 17% | 22% | 55% |
| Peers Return | 24% | -11% | 25% | 12% | 6% | 18% | 91% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 1% | 85% |
Monthly Win Rates [3] | |||||||
| NDSN Win Rate | 67% | 50% | 58% | 50% | 67% | 100% | |
| Peers Win Rate | 63% | 35% | 57% | 57% | 57% | 100% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 100% | |
Max Drawdowns [4] | |||||||
| NDSN Max Drawdown | -11% | -23% | -14% | -20% | -19% | 0% | |
| Peers Max Drawdown | -7% | -29% | -5% | -8% | -17% | 0% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: GGG, ITW, PH, DOV, IEX. See NDSN Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/12/2026 (YTD)
How Low Can It Go
| Event | NDSN | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -27.8% | -25.4% |
| % Gain to Breakeven | 38.5% | 34.1% |
| Time to Breakeven | 615 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -44.4% | -33.9% |
| % Gain to Breakeven | 79.7% | 51.3% |
| Time to Breakeven | 66 days | 148 days |
| 2018 Correction | ||
| % Loss | -26.8% | -19.8% |
| % Gain to Breakeven | 36.6% | 24.7% |
| Time to Breakeven | 315 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -74.1% | -56.8% |
| % Gain to Breakeven | 285.4% | 131.3% |
| Time to Breakeven | 595 days | 1,480 days |
Compare to GGG, ITW, PH, DOV, IEX
In The Past
Nordson's stock fell -27.8% during the 2022 Inflation Shock from a high on 12/10/2021. A -27.8% loss requires a 38.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Nordson (NDSN)
Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids worldwide. It operates through two segments, Industrial Precision Solutions (IPS) and Advanced Technology Solutions (ATS). The IPS segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems used in packaged goods industries; components and systems used in the thermoplastic melt stream; and product assembly systems for use in paper and paperboard converting applications, and manufacturing roll goods, as well as for the assembly of plastic, metal, and wood products. It also offers automated and manual dispensing products and systems to apply adhesive and sealant materials; dispensing and curing systems to coat and cure containers; systems to apply liquid paints and coatings to consumer and industrial products; and systems to apply powder paints and coatings to metal, plastic, and wood products, as well as ultraviolet equipment for use in curing and drying operations for specialty coatings, semiconductor materials, and paints. The ATS segment provides automated dispensing systems for the attachment, protection, and coating of fluids, as well as related gas plasma treatment systems for cleaning and conditioning surfaces; precision manual and semi-automated dispensers, minimally invasive interventional delivery devices, plastic molded syringes, cartridges, tips, fluid connection components, tubing, balloons, and catheters; and bond testing and automated optical, acoustic microscopy, and x-ray inspection systems for use in semiconductor and printed circuit board industries. The company markets its products through direct sales force, as well as distributors and sales representatives. Nordson Corporation was founded in 1935 and is headquartered in Westlake, Ohio.
AI Analysis | Feedback
Parker Hannifin for precision industrial material application.
Rockwell Automation, but for dispensing and coating solutions in manufacturing.
A diversified ASML for general industrial manufacturing processes.
AI Analysis | Feedback
- Precision Dispensing Systems: Nordson provides equipment for the precise application of adhesives, sealants, coatings, and other materials in manufacturing processes across various industries.
- Fluid Management Components: The company offers specialized components and systems for managing, transferring, and dispensing critical fluids, especially within the medical and life sciences sectors.
- Test and Inspection Systems: Nordson manufactures advanced equipment for quality control, including automated optical inspection, X-ray inspection, and metrology solutions for complex manufacturing.
- Surface Treatment and Curing Systems: They develop technologies for preparing surfaces, such as plasma treatment, and for curing materials like UV curing, used in various industrial applications.
AI Analysis | Feedback
Nordson (NDSN) primarily sells its products and services to other companies (Business-to-Business, or B2B).
According to Nordson's financial filings (e.g., their most recent 10-K), the company has a highly diversified customer base, and no single customer accounted for 10% or more of its consolidated net sales in recent fiscal years. Therefore, Nordson does not have "major customers" in the traditional sense of a few dominant clients that represent a significant portion of its revenue.
Instead, Nordson serves thousands of manufacturing companies globally across a wide array of end markets. Its customers are typically original equipment manufacturers (OEMs) and end-users of its precision dispensing, fluid management, test and inspection, and surface treatment technologies. While specific customer names are not disclosed due to the diversified nature of their business, their customer base consists of companies in the following key industries:
- Consumer Non-Durable Goods Manufacturing: This category includes companies producing products like diapers, feminine hygiene products, and various types of packaging (for food, beverages, and other consumer goods) that rely on Nordson's precision dispensing of adhesives, sealants, and coatings.
- Consumer Durable Goods Manufacturing: Manufacturers in sectors such as automotive (e.g., car manufacturers and their suppliers for components), appliances, electronics, and construction, which use Nordson's systems for coating, bonding, and sealing applications.
- Electronics Manufacturing: Companies involved in the production of semiconductors, printed circuit boards (PCBs), and advanced electronic components, utilizing Nordson's dispensing, inspection, and test equipment for precision assembly and quality control.
- Medical Device Manufacturing: Businesses that produce a wide range of medical devices, including catheters, syringes, and other critical components, where Nordson's fluid management and dispensing technologies are essential for precision assembly and material processing.
AI Analysis | Feedback
null
AI Analysis | Feedback
Sundaram Nagarajan, President and Chief Executive Officer Sundaram "Naga" Nagarajan has served as President and Chief Executive Officer of Nordson Corporation since August 2019. Prior to joining Nordson, he had a 23-year career with Illinois Tool Works Inc. (ITW), a Fortune 200 company, where he held various roles of increasing responsibility, most recently as the Executive Vice President for the ITW Automotive OEM Segment. Under his leadership, the Automotive OEM segment consistently achieved profitable revenue growth through both organic means and acquisitions. He also served as a director of Sonoco Products Company from 2015 to 2022. Daniel Hopgood, Executive Vice President and Chief Financial Officer Daniel Hopgood was named Executive Vice President and Chief Financial Officer of Nordson Corporation, effective May 20, 2024. He brings over 25 years of financial and operational expertise to this role. Before joining Nordson, he held roles of increasing responsibility at Eaton Corporation, a multinational power management company, most recently serving as its controller and chief accounting officer. His prior experience also includes positions at Meritor, Inc., MSX International, Inc., Delphi Automotive Systems Corporation, and PricewaterhouseCoopers. Stephen P. Lovass, Executive Vice President, Medical and Fluid Solutions Segment Stephen P. Lovass serves as Executive Vice President, leading Nordson's Medical and Fluid Solutions (MFS) segment, and previously led the Strategy and Corporate Development Group. He joined Nordson in 2016 as the leader of the Industrial Coating Systems business. Prior to Nordson, he served as president for one of the global sensors and controls businesses at Danaher Corporation, a diversified science and technology company. He also held senior roles in Strategic Planning and General Management based in the U.S., Europe, and Asia, and spent ten years with Gerber Scientific Inc., where he ran three of the company's four businesses. Jeffrey A. Pembroke, Executive Vice President, Industrial Precision Solutions Segment Jeffrey A. Pembroke leads Nordson's Industrial Precision Solutions (IPS) segment as Executive Vice President. He joined Nordson in 2005 and has been instrumental in driving growth across various Nordson businesses, including building the Nordson MEDICAL acquisition strategy and the company's growth and innovation platform. Before joining Nordson, Mr. Pembroke spent 16 years at General Electric, where he held various leadership roles in finance, sales, marketing, and general management within GE's Advanced Materials division. He also formerly served as Co-Managing Director of Liquidyn GmbH, which manufactures micro dispensing valves. Jennifer L. McDonough, Executive Vice President, General Counsel, and Secretary Jennifer L. McDonough serves as Executive Vice President, General Counsel, and Secretary, overseeing Nordson's global legal, governance, compliance, and sustainability functions. She joined Nordson in November 2021. With over 20 years of experience, her previous roles include vice president, deputy general counsel, and assistant secretary at PPL Corporation, general counsel at REX Energy Corporation, and assistant general counsel at Kennametal Inc. She began her legal career as a litigation associate with the international law firm Morgan, Lewis and Bockius LLP.AI Analysis | Feedback
The key risks to Nordson's business (NDSN) are primarily linked to global economic dynamics, currency volatility, and the execution of its acquisition strategy.
- Global Economic Conditions and Market Demand: Nordson's profitability and sales are significantly influenced by U.S. and international economic and market conditions. The company serves diverse end markets, including packaging, electronics, medical, and automotive, making it susceptible to downturns or fluctuations in these industries. For instance, specific product lines, such as electronics/semiconductors, have demonstrated cyclicality, experiencing periods of both strong growth and weaker demand.
- Foreign Currency Exchange Rate Fluctuations: A substantial portion of Nordson's revenue, approximately 60%, comes from international sales. Consequently, the company is exposed to market risk arising from movements in currency exchange rates, which can positively or negatively impact financial results.
- Acquisition and Divestiture Integration Risks: Nordson actively pursues acquisitions as part of its growth strategy. The company's ability to successfully integrate acquired businesses and, conversely, to effectively divest or dispose of businesses that no longer align with its strategic plan, poses a significant risk. Unsuccessful integration can hinder anticipated synergies and financial performance.
AI Analysis | Feedback
null
AI Analysis | Feedback
Nordson Corporation (NDSN) participates in several global markets through its main product segments, including industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The addressable markets for some of Nordson's key products and services are as follows:
- Adhesive Dispensing Systems: The global adhesive dispensing system market was valued at approximately USD 37.55 billion in 2025 and is projected to grow to USD 47.27 billion by 2030, at a compound annual growth rate (CAGR) of 5.23%.
- Industrial Dispensing Systems and Equipment: The global industrial dispensing system and equipment market was valued at $14.08 billion in 2022, with an expected increase to $15.28 billion in 2023, and a projection to reach $20.27 billion by 2027, growing at a CAGR of 7.3%. Another report indicates the global dispensing system market is projected to grow from USD 56.5 billion in 2025 to USD 108.1 billion by 2035, at a CAGR of 6.7%.
- Industrial Coatings: The global industrial coatings market was valued at USD 112.04 billion in 2024 and is projected to reach USD 142.35 billion by 2030, with a CAGR of 4.12% from 2025 to 2030.
- Coating Equipment: The global coating equipment market was valued at $18.38 billion in 2021, grew to $20.23 billion in 2022, and is expected to reach $26.05 billion in 2026, growing at a CAGR of 6.5%.
For Nordson's Medical and Fluid Solutions segment, while the company develops various therapeutic devices, including catheters, cannulae, and fluid management systems, a comprehensive addressable market size for this entire segment beyond its contribution to the broader dispensing systems market was not readily available in the search results.
AI Analysis | Feedback
Nordson Corporation (NDSN) is anticipated to drive future revenue growth over the next two to three years through several key strategies and market dynamics:
- Strategic Acquisitions and Integration: Acquisitions, such as the Atrion business, are expected to continue contributing significantly to Nordson's revenue growth. The Atrion acquisition, closed in August 2024, delivered $53 million in revenue in the first quarter of fiscal year 2025 and accounted for 8% of total sales growth in the third quarter of fiscal year 2025. Management has expressed satisfaction with Atrion's integration, noting its positive impact on adjusted earnings per share. The company also maintains a healthy merger and acquisition pipeline, indicating that strategic inorganic growth will remain a focus.
- Growth in Advanced Technology Solutions (ATS) and Semiconductor/Electronics Markets: The Advanced Technology Solutions (ATS) segment is a strong driver, demonstrating double-digit organic sales growth for two consecutive quarters in fiscal year 2025. This growth is primarily fueled by increasing demand in electronics and semiconductor end-markets, including semiconductor packaging and electronics assembly, driven by advancements in AI, cloud computing, and advanced consumer devices.
- New Product Development and Innovation: Nordson emphasizes technology and innovation as crucial for its success, with CEO Sundaram Nagarajan stating, "Nordson wins with technology. New products are essential." The company's "NBS Next growth framework" is designed to ensure that new products are a consistent source of organic growth and a competitive advantage. Strategic initiatives focused on product innovations are expected to contribute to future revenue expansion.
- Recovery and Streamlining of Medical and Industrial Segments: Nordson anticipates a return to normal growth in its medical segment by fiscal year 2026, following challenges such as destocking trends in medical interventional product lines observed in fiscal year 2024 and early fiscal year 2025. Similarly, improvement is expected in the Industrial Precision Solutions (IPS) segment by fiscal year 2026. Furthermore, the planned divestiture of its medical contract manufacturing business is set to streamline operations and allow for a greater focus on higher-value proprietary medical components, which is expected to enhance the growth profile of the remaining medical business.
AI Analysis | Feedback
Share Repurchases
- Nordson's Board of Directors authorized an additional $500 million for its share repurchase program on September 6, 2022, increasing the total capacity to $660 million.
- On August 20, 2025, a new $500 million share repurchase authorization was approved, bringing the total available authorization to approximately $793 million.
- Year-to-date as of the third quarter of fiscal year 2025, the company repurchased $212 million in shares.
Outbound Investments
- On November 3, 2022, Nordson completed the acquisition of CyberOptics Corporation, aiming to expand its product offerings in the semiconductor and electronics industries.
- In 2023, Nordson acquired Arag Srl for $960 million, a global leader in precision control systems and smart fluid components for agricultural spraying.
- Nordson completed the acquisition of Atrion in August 2024, further shifting its focus towards high-growth sectors like medical devices.
Capital Expenditures
- Capital expenditures were approximately $49.7 million in fiscal year 2024, $38.1 million in fiscal year 2023, and $51.2 million in fiscal year 2022.
- Projected capital expenditures are $55 million for fiscal year 2025 and are expected to remain around 2% of revenue through fiscal year 2029.
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 262.62 |
| Mkt Cap | 24.1 |
| Rev LTM | 5,672 |
| Op Inc LTM | 1,024 |
| FCF LTM | 643 |
| FCF 3Y Avg | 743 |
| CFO LTM | 751 |
| CFO 3Y Avg | 873 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 2.8% |
| Rev Chg 3Y Avg | 1.8% |
| Rev Chg Q | 4.7% |
| QoQ Delta Rev Chg LTM | 1.2% |
| Op Mgn LTM | 23.5% |
| Op Mgn 3Y Avg | 23.6% |
| QoQ Delta Op Mgn LTM | 0.3% |
| CFO/Rev LTM | 19.7% |
| CFO/Rev 3Y Avg | 20.4% |
| FCF/Rev LTM | 17.5% |
| FCF/Rev 3Y Avg | 17.9% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 24.1 |
| P/S | 5.7 |
| P/EBIT | 23.1 |
| P/E | 31.8 |
| P/CFO | 25.2 |
| Total Yield | 4.4% |
| Dividend Yield | 1.1% |
| FCF Yield 3Y Avg | 3.8% |
| D/E | 0.1 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 10.4% |
| 3M Rtn | 22.9% |
| 6M Rtn | 26.5% |
| 12M Rtn | 17.7% |
| 3Y Rtn | 34.4% |
| 1M Excs Rtn | 12.3% |
| 3M Excs Rtn | 22.2% |
| 6M Excs Rtn | 18.7% |
| 12M Excs Rtn | 4.1% |
| 3Y Excs Rtn | -28.5% |
Comparison Analyses
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Industrial Precision Solutions | 1,399 | 1,391 | 1,337 | 1,247 | 1,143 |
| Medical and Fluid Solutions | 695 | 660 | 690 | 642 | |
| Advanced Technology Solutions | 596 | 577 | 563 | 474 | 978 |
| Corporate | 0 | 0 | |||
| Total | 2,690 | 2,629 | 2,590 | 2,362 | 2,121 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Industrial Precision Solutions | 498 | 461 | 434 | 414 | 208 |
| Medical and Fluid Solutions | 234 | 189 | 217 | 198 | |
| Advanced Technology Solutions | 123 | 102 | 133 | 73 | 192 |
| Divestiture and related charges | 0 | ||||
| Inventory step-up amortization | -8 | ||||
| Acquisition related costs | -14 | ||||
| Severance and other | -17 | ||||
| Corporate expenses | -57 | ||||
| Depreciation and amortization | -85 | ||||
| Corporate | -79 | -83 | -71 | -50 | |
| Total | 674 | 673 | 702 | 615 | 350 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Medical and Fluid Solutions | 2,252 | 1,544 | 1,559 | 1,519 | |
| Industrial Precision Solutions | 1,699 | 1,933 | 1,113 | 965 | 883 |
| Corporate | 1,186 | 1,105 | 813 | 968 | 948 |
| Advanced Technology Solutions | 864 | 730 | 397 | 395 | 1,849 |
| Eliminations | -61 | -62 | -55 | -48 | |
| Customer advance payments | 42 | ||||
| Total | 6,001 | 5,252 | 3,820 | 3,791 | 3,675 |
Price Behavior
Price Behavior
| Market Price | $294.67 | |
| Market Cap ($ Bil) | 16.5 | |
| First Trading Date | 03/26/1990 | |
| Distance from 52W High | -0.4% | |
| 50 Days | 200 Days | |
| DMA Price | $257.98 | $228.25 |
| DMA Trend | up | up |
| Distance from DMA | 14.2% | 29.1% |
| 3M | 1YR | |
| Volatility | 18.1% | 27.3% |
| Downside Capture | 8.77 | 86.24 |
| Upside Capture | 144.09 | 108.63 |
| Correlation (SPY) | 53.8% | 74.8% |
NDSN Betas & Captures as of 1/31/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.39 | 1.07 | 0.84 | 0.88 | 1.06 | 1.02 |
| Up Beta | 2.82 | 2.45 | 1.07 | 1.35 | 1.18 | 1.17 |
| Down Beta | 1.27 | 0.80 | 0.59 | 0.64 | 0.97 | 0.99 |
| Up Capture | 245% | 181% | 146% | 114% | 109% | 66% |
| Bmk +ve Days | 11 | 22 | 34 | 71 | 142 | 430 |
| Stock +ve Days | 16 | 29 | 38 | 73 | 132 | 379 |
| Down Capture | -32% | 12% | 45% | 58% | 97% | 100% |
| Bmk -ve Days | 9 | 19 | 27 | 54 | 109 | 321 |
| Stock -ve Days | 4 | 12 | 23 | 52 | 118 | 372 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NDSN | |
|---|---|---|---|---|
| NDSN | 38.2% | 27.3% | 1.16 | - |
| Sector ETF (XLI) | 26.0% | 19.2% | 1.08 | 78.5% |
| Equity (SPY) | 13.6% | 19.4% | 0.53 | 74.5% |
| Gold (GLD) | 70.2% | 25.2% | 2.08 | 2.6% |
| Commodities (DBC) | 5.5% | 16.8% | 0.15 | 25.7% |
| Real Estate (VNQ) | 5.4% | 16.6% | 0.14 | 68.6% |
| Bitcoin (BTCUSD) | -29.6% | 44.7% | -0.65 | 30.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NDSN | |
|---|---|---|---|---|
| NDSN | 10.6% | 24.8% | 0.40 | - |
| Sector ETF (XLI) | 15.9% | 17.2% | 0.75 | 72.8% |
| Equity (SPY) | 13.4% | 17.0% | 0.62 | 66.3% |
| Gold (GLD) | 21.8% | 17.0% | 1.05 | 7.0% |
| Commodities (DBC) | 10.8% | 18.9% | 0.45 | 14.0% |
| Real Estate (VNQ) | 5.0% | 18.8% | 0.17 | 58.7% |
| Bitcoin (BTCUSD) | 12.1% | 57.9% | 0.43 | 21.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with NDSN | |
|---|---|---|---|---|
| NDSN | 18.5% | 28.8% | 0.64 | - |
| Sector ETF (XLI) | 15.1% | 19.8% | 0.67 | 72.0% |
| Equity (SPY) | 15.4% | 17.9% | 0.74 | 68.5% |
| Gold (GLD) | 15.2% | 15.6% | 0.81 | 1.8% |
| Commodities (DBC) | 8.0% | 17.6% | 0.37 | 22.8% |
| Real Estate (VNQ) | 6.1% | 20.7% | 0.26 | 56.5% |
| Bitcoin (BTCUSD) | 67.5% | 66.7% | 1.07 | 15.4% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 12/10/2025 | -0.8% | 0.7% | 11.0% |
| 8/20/2025 | 3.0% | 5.7% | 5.8% |
| 5/28/2025 | 6.8% | 8.9% | 10.3% |
| 2/19/2025 | 0.3% | -3.1% | -5.2% |
| 12/11/2024 | -8.2% | -14.7% | -16.6% |
| 8/21/2024 | 3.3% | 3.8% | 3.5% |
| 5/20/2024 | -9.4% | -13.0% | -13.6% |
| 2/21/2024 | 4.5% | 2.0% | 3.2% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 14 | 13 | 11 |
| # Negative | 7 | 8 | 10 |
| Median Positive | 2.5% | 4.8% | 5.8% |
| Median Negative | -6.4% | -6.3% | -6.0% |
| Max Positive | 7.1% | 9.5% | 11.3% |
| Max Negative | -9.4% | -14.7% | -33.0% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 10/31/2025 | 12/17/2025 | 10-K |
| 07/31/2025 | 08/21/2025 | 10-Q |
| 04/30/2025 | 05/29/2025 | 10-Q |
| 01/31/2025 | 02/20/2025 | 10-Q |
| 10/31/2024 | 12/18/2024 | 10-K |
| 07/31/2024 | 08/22/2024 | 10-Q |
| 04/30/2024 | 05/23/2024 | 10-Q |
| 01/31/2024 | 02/22/2024 | 10-Q |
| 10/31/2023 | 12/20/2023 | 10-K |
| 07/31/2023 | 08/24/2023 | 10-Q |
| 04/30/2023 | 05/25/2023 | 10-Q |
| 01/31/2023 | 02/23/2023 | 10-Q |
| 10/31/2022 | 12/19/2022 | 10-K |
| 07/31/2022 | 08/26/2022 | 10-Q |
| 04/30/2022 | 05/27/2022 | 10-Q |
| 01/31/2022 | 02/25/2022 | 10-Q |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Devries, James E | Executive Vice President | Direct | Sell | 11122025 | 233.60 | 9,100 | 2,125,760 | 11,965,693 | Form |
| 2 | Morris, Milton Mayo | Direct | Sell | 11032025 | 231.00 | 265 | 61,215 | 670,131 | Form | |
| 3 | Kelley, Joseph P | Executive Vice President | Direct | Sell | 10222025 | 240.00 | 2,200 | 528,000 | 1,537,200 | Form |
| 4 | Kelley, Joseph P | Executive Vice President | Direct | Sell | 10202025 | 232.39 | 2,300 | 534,497 | 1,999,716 | Form |
| 5 | Lovass, Stephen | Executive Vice President | Direct | Sell | 1082025 | 206.79 | 1,299 | 268,620 | 1,519,286 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.